Clinuvel Pharmaceuticals Ltd
- Last sale
- Nov 3, 2026 · -6.70%
- Market cap
- $249.37M
- 50.43M shares
- Filings
- 49
FY 2026+5.2% FY26 yoy
FY 2026+0.2% FY26 yoy
FY 2026+5.3% FY26 yoy
FY 2026derived−56.3% FY26 yoy
FY 2026±0.0% FY26 yoy
FY 2026−23.0% FY26 yoy
- $249.37M
- 10.8×
- 3.9×
- 1.3×
- 4.75%
- 0.67%
FY2026 figures · derived
Price
Nov 3, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $64,315,354 | reported | |
| FY 2025 | 2025-06-30 | $61,120,888 | reported | |
| FY 2024 | 2024-06-30 | $57,911,843 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | $1.67M | — | $1.67M | — | 50.43M sh | +0.6% | 14.1% |
| FY2025 | $1.69M | $173.97K | $1.87M | — | 50.12M sh | — | 6.9% |
| FY2024 | $1.59M | $497.66K | $2.09M | — | — | — | 10.4% |
Segments
LineFY2026ShareChange
IRELAND$36.04M56%+21.0%
UNITED STATES$27.73M43%−9.9%
Rest of World$553.11K0.9%−5.3%
Total$64.32M
Peers
American depositary receipts
Clinuvel Pharmaceuticals Ltd is the only covered company the SEC files under this code. SIC 8880
CompanyRevenueGrowthNet marginMarket cap
CUVLClinuvel Pharmaceuticals Ltd (this company)$64.3M5.2%36.0%$249.4M
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Clinuvel Pharmaceuticals Ltd · CIK 1290877 · Engraved from SEC EDGAR